Atopic dermatitis (eczema)

Regular use of thick, fragrance-free creams or ointments to keep water in the skin and support the skin barrier. This is the base of nearly every eczema plan.

It is commonly recommended for all people with AD, including when the skin looks clear, and it is often used alongside other treatments.

A specific product stings, burns, or causes a rash. Some products contain fragrance, botanical extracts, or other ingredients that bother sensitive skin. Be cautious with products in large tubs that fingers can contaminate, and with food-based oils on babies.

Stinging, new redness, or bumps after applying a product. Ointments feel greasy but often hold in more moisture than lotions.

Many people notice softer, less itchy skin within days to a couple of weeks. The benefit builds with steady use over months.

• Which type of moisturizer (cream or ointment) fits my skin and climate?
• How often and when do you suggest I apply it around bathing?
• Are there ingredients I should look for or avoid because of my skin?

Short, lukewarm baths or showers with a mild, fragrance-free cleanser, followed by patting the skin dry and moisturizing soon after. Some clinicians also discuss diluted bleach baths for certain people.

It is often discussed when skin is dry, flares follow hot or long showers, or skin gets infected often. Bleach baths are generally considered only under a clinician's direction and are not for everyone.

Skin is open, raw, or very irritated, or bleach has stung or irritated skin before. Bleach baths are generally discussed with a clinician first, especially for children.

Stinging, dryness, or more redness after bathing. Foamy bubble baths and scented soaps can irritate. Watch for slippery floors with oils.

Changes in dryness and itch are often noticeable within a couple of weeks.

• Is my current bathing routine helping or hurting my skin?
• Would bleach baths ever make sense for me, and how do I do that safely?
• What cleanser features should I look for?

Practical steps such as short, smooth nails, soft cotton layers, fragrance-free laundry products, and a cool, humidified bedroom, along with testing for allergies only when a clinician thinks it is useful.

These steps are commonly suggested to all people with AD, and especially when scratching at night, sweating, or certain fabrics clearly set off flares.

Avoid-everything approaches that become stressful or restrict food without medical advice. Home humidifiers need regular cleaning to prevent mold.

Allergy tests can be positive without meaning the item causes eczema flares, so results need a clinician's interpretation.

Environment changes can take a few weeks to show a difference.

• Which triggers are worth my effort to change?
• Is allergy testing useful for me or my child?
• How can I help a child avoid scratching at night?

Non-prescription options such as mild hydrocortisone products, cool compresses, and, for some people, colloidal oatmeal products or wet wrap techniques taught by a clinician.

They are often discussed for mild flares or between prescription treatments. Wet wraps are usually reserved for more stubborn flares and are taught by a clinician.

Skin is oozing or infected, the person is an infant, or the product contains fragrance or other irritants. Sedating antihistamines are not a proven fix for the itch of eczema and may not be a good fit for children or older adults.

Irritation or allergy to an added ingredient, and overuse of steroid products on thin skin. Persistent itch despite these steps is a reason to check in with a clinician.

Within about a week, you can usually tell if a product is helping.

• Which over-the-counter products are reasonable for me?
• Are wet wraps something I should consider?
• Do antihistamines have any role for my itch or sleep?

Anti-inflammatory medicines applied to the skin that come in a range of strengths. They are a long-standing, first-line treatment for flares.

They are commonly considered for red, itchy, inflamed patches that do not settle with moisturizing alone. Clinicians choose the strength based on age, body area, and how severe the rash is.

Skin is infected, or on thin-skin areas such as the face, folds, and genitals unless a clinician has planned it. Use during pregnancy, in babies, and over large areas needs clinician guidance.

Skin thinning, stretch marks, or visible small blood vessels with long or heavy use, and lightening of the skin, which can be more noticeable on brown and Black skin. Many people also worry about steroids, and these concerns deserve a direct conversation. When used as directed by a clinician, serious problems are uncommon.

A flare often starts to improve within days to about two weeks. Your clinician will say when to check back.

• Which strength is right for which body areas?
• How will we decide when to stop or step down?
• Are there steroid-free options if I am worried about side effects?

Prescription creams and ointments that calm inflammation without being steroids. Classes include calcineurin inhibitors (such as tacrolimus and pimecrolimus), PDE4 inhibitors (such as crisaborole and roflumilast), and a topical JAK inhibitor (ruxolitinib), plus tapinarof, which works through a different pathway.

They are often considered for sensitive areas like the face, eyelids, and skin folds, for long-term control to help prevent flares, or when steroids are not working or not preferred. Age limits and approved uses differ by product.

Skin is infected, there is a known allergy to the product, or the person is very young (age limits apply). Use in pregnancy or breastfeeding should be discussed with a clinician. Cost and insurance coverage can also be limiting.

Burning or stinging when first applied, which often fades. Some products carry safety warnings that your clinician can explain, and sun protection is often advised on treated skin.

Often judged over about two to four weeks, though some work faster.

• Which non-steroid option fits my age and the areas affected?
• What does the safety information say, and how does it apply to me?
• Would I use this for flares only or for ongoing control?

Controlled exposure to specific ultraviolet light, usually narrowband UVB, given in a medical setting several times a week for a period of weeks.

It is often considered for widespread eczema that has not responded enough to topical treatment, in older children and adults, and when a person can get to a treatment center regularly.

Travel to frequent visits is not possible, there is a history of skin cancer or a light-sensitive condition, or certain medicines make the skin sun-sensitive. Tanning beds are not a substitute.

Sunburn-like redness, dryness, itching, and tanning. Over many years, UV exposure raises skin cancer concerns, so clinicians keep treatment courses limited.

Often judged after about 8 to 12 weeks of regular sessions.

• Am I a candidate for phototherapy, and where can I get it?
• How many visits does it usually take, and what are the long-term skin cancer considerations?
• How would phototherapy fit with my other treatments?

Pills that act on the whole body. JAK inhibitors calm several immune signals at once. Older immune-suppressing medicines are also sometimes used. Upadacitinib is one JAK inhibitor; per its FDA label it is indicated for adults and children 12 and older with refractory, moderate-to-severe AD not well controlled with other systemic medicines, including biologics, or when those are inadvisable.

They are often considered for moderate to severe AD that has not been controlled by other approaches, when a clinician judges that the benefits are worth the risks. Short courses of oral steroids are generally avoided for long-term eczema care.

There is a history of certain heart or clot problems, cancer, or serious infection, or the person smokes or is older. JAK inhibitors are not used in pregnancy or when planning pregnancy without careful review.

JAK inhibitors carry boxed warnings (the FDA's strongest) for serious infections, death, cancer, major heart events, and blood clots. Blood tests are typically monitored. Acne and cold sores are also reported.

Often judged over about 1 to 3 months, with regular check-ins.

• Why would a pill be considered for me instead of an injection or light therapy?
• What are the boxed-warning risks, and do my health history and age raise them?
• What monitoring and blood tests would I need?

Targeted injections that block specific immune signals involved in eczema, such as IL-4, IL-13, and IL-31. Dupilumab is one example. According to its FDA label, it is approved for adults and children 6 months and older with moderate-to-severe AD not well controlled with prescription topical therapies, or when those therapies are not advisable. Other biologics aimed at IL-13 are also available for older children and adults.

They are often considered when AD is moderate to severe, affects daily life or sleep, and has not been controlled well enough with topical care, with or without light therapy.

There is an active serious infection, a known allergy to the medicine, or plans that need review, such as pregnancy. Live vaccines are usually reviewed before starting. Eligibility depends on age, severity, and insurance rules.

Injection-site reactions, eye problems such as red, itchy, or dry eyes (conjunctivitis), and cold sores can occur. Tell your clinician about any new eye symptoms. Regular follow-up is typical.

Often judged over about 3 to 4 months, with benefits continuing to build for some people.

• Do I meet the criteria for a biologic, and what would insurance require?
• What eye or other side effects should I watch for?
• What happens if the first biologic does not work well enough for me?